India to Pakistan: Sofosbuvir Export Trade Route

The India to Pakistan Sofosbuvir corridor is one of India's established pharmaceutical export routes, with 6 shipments documented worth a combined $2.4M USD. The route is dominated by MYLAN LABORATORIES LIMITED , which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's sofosbuvir manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $400.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with sofosbuvir's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 32.4%, placing it at rank #6 among India's top sofosbuvir export destinations globally.

On the import side, key buyers of Indian sofosbuvir in Pakistan include AGP LIMITED, , AGP LIMITED, NATIONAL TB CONTROL PROGRAM (NTP) and 2 others. AGP LIMITED, is the single largest importer with 1 shipments valued at $1.1M USD.

India's sofosbuvir exports to Pakistan are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Pakistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED , MYLAN LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $400.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as myhep sofosbuvir 400mg 28 tablet 28 s and sofosbuvir 400mg + velpatasvir 100mg tablets (28s)- myhep all (qty. 5310.000 packs x 28s bottle= ttl qty. 148,680 nos), suggesting that buyers in Pakistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AGP LIMITED, is the largest importer with 1 shipments worth $1.1M USD — representing 44% of all sofosbuvir imports from India on this route.